Vapogenix Revenue and Competitors

Vapogenix is a clinical stage company developing a new class of non-narcotic analgesics for localized pain. While most pain is localized, most pain medications are administered orally (systemically), resulting in side effects. We are focused on treating pain locally – at its source. Our products are formulated volatile anesthetics; currently unformulated volatile anesthetics are used only as general anesthetics, by inhalation. Our first product, which recently completed its first clinical trial, is a rapidly acting topical analgesic to alleviate pain associated with venipuncture, venous cannulation and minor dermatological procedures. Our next products will focus on treating wound pain and localized inflammatory pain.